Home » Topics » BioWorld Science

BioWorld Science
RSS

Covis Pharma initiates phase III study of Alvesco inhaler for the treatment of COVID-19

May 20, 2020

New in vivo data support prophylactic treatment potential of brilacidin against COVID-19

May 20, 2020

Vividion and Roche collaborate to discover and develop small molecules targeting E3 ligase

May 20, 2020

Phase II study of MGB-BP-3 in CDI meets primary endpoints

May 20, 2020

Subdividing and conquering PDAC

May 20, 2020

Antitumor activity seen with GPC3-CAR T-cell therapy in children with liver tumors

May 20, 2020

FDA authorizes IND application for MSC product for COVID-19-related ARDS

May 20, 2020

Phase IIb study of Liproca Depot in prostate cancer meets endpoints

May 19, 2020

European Commission grants conditional approval for Zolgensma for SMA

May 19, 2020

Sorrento's STI-1499 demonstrates 100% inhibition of SARS-CoV-2 virus infection in vivo

May 19, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...